Special Considerations of Management of ALL in the Adolescent and Young Adult
This information was originally presented on September 14, 2012, at the NCCN 7th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Identify NCCN's recommendations for the management of ALL in the AYA populations
- Summarize the various supportive care needs of young adult patients receiving treatment for ALL
- Counsel patients and caregivers regarding ALL treatment compliance and management of therapy-related side effects
Daniel J. DeAngelo, MD, PhD
Dana-Farber/Brigham and Women’s Cancer Center
- 0.75 Participation
- 0.70 Nurse
- 0.75 Pharmacist
- 0.75 Physician